X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
egfr-tkis (193) 193
index medicus (132) 132
oncology (119) 119
humans (105) 105
gefitinib (99) 99
chemotherapy (85) 85
lung cancer (84) 84
mutation (82) 82
erlotinib (71) 71
lung neoplasms - drug therapy (71) 71
nsclc (69) 69
epidermal growth factor (68) 68
carcinoma, non-small-cell lung - drug therapy (67) 67
respiratory tract diseases (66) 66
open-label (63) 63
lung cancer, non-small cell (55) 55
acquired-resistance (53) 53
female (52) 52
male (49) 49
tyrosine (49) 49
cancer (48) 48
middle aged (47) 47
non-small cell lung cancer (47) 47
protein kinase inhibitors - therapeutic use (45) 45
egfr (44) 44
lung neoplasms - genetics (43) 43
aged (42) 42
1st-line treatment (41) 41
egfr tkis (41) 41
carcinoma, non-small-cell lung - genetics (37) 37
adenocarcinoma (36) 36
cancer therapies (36) 36
lung neoplasms - pathology (36) 36
metastasis (36) 36
receptor, epidermal growth factor - antagonists & inhibitors (36) 36
neoplasms. tumors. oncology. including cancer and carcinogens (35) 35
growth-factor receptor (34) 34
respiratory system (34) 34
adult (33) 33
care and treatment (33) 33
cell lung-cancer (33) 33
kinases (33) 33
lung neoplasms (32) 32
tyrosine kinase inhibitors (32) 32
carcinoma, non-small-cell lung - pathology (31) 31
resistance (31) 31
non-small cell lung carcinoma (30) 30
receptor, epidermal growth factor - genetics (30) 30
treatment outcome (29) 29
antineoplastic agents - therapeutic use (28) 28
epidermal growth factor receptors (28) 28
analysis (27) 27
aged, 80 and over (26) 26
cell biology (24) 24
prognosis (24) 24
review (24) 24
mutations (23) 23
quinazolines - therapeutic use (23) 23
egfr mutations (22) 22
expression (22) 22
genetic aspects (22) 22
肺肿瘤 (22) 22
erbb receptors - genetics (21) 21
lung adenocarcinoma (21) 21
meta-analysis (21) 21
patients (21) 21
protein-tyrosine kinase (21) 21
therapy (21) 21
egfr mutation (20) 20
medical prognosis (20) 20
disease-free survival (19) 19
drug resistance (19) 19
multicenter (19) 19
retrospective studies (19) 19
cell line, tumor (18) 18
lung cancer, small cell (18) 18
lung neoplasms - metabolism (18) 18
protein kinase inhibitors - pharmacology (18) 18
survival (18) 18
tyrosine kinase inhibitor (17) 17
animals (16) 16
apoptosis (16) 16
pharmacology & pharmacy (16) 16
tumors (16) 16
afatinib (15) 15
antineoplastic agents - pharmacology (15) 15
development and progression (15) 15
drug resistance, neoplasm (15) 15
efficacy (15) 15
erbb receptors - antagonists & inhibitors (15) 15
lung neoplasms - mortality (15) 15
phase-iii trial (15) 15
phenols (15) 15
protein kinase inhibitors - administration & dosage (15) 15
research (15) 15
egfr‐tkis (14) 14
non-small-cell lung cancer (14) 14
phase-iii (14) 14
studies (14) 14
brain metastases (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical Pharmacology, ISSN 0006-2952, 02/2020, Volume 172, p. 113772
[Display omitted] Patients with epidermal growth factor receptor (EGFR)-mutant advanced non-small-cell lung cancer (NSCLC) benefits from EGFR-tyrosine kinase... 
TFAP2A | EGFR-TKIs | DACT2 | Lung adenocarcinoma | Genetic polymorphism
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 2012, Volume 1, Issue 4, pp. 287 - 288
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 2013, Volume 2, Issue 1, pp. 58 - 61
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 2012, Volume 1, Issue 4, pp. 280 - 282
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 2013, Volume 2, Issue 1, pp. 50 - 54
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 2013, Volume 2, Issue 1, pp. 62 - 63
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 2013, Volume 2, Issue 1, pp. 55 - 57
Journal Article
Cancer Biology & Therapy, ISSN 1538-4047, 01/2020, Volume 21, Issue 1, pp. 61 - 71
EGFR-TKIs such as erlotinib and gefitinib have been introduced into the first-line treatment for patients having a mutation of deletion in exon 19 or L858R... 
EGFR-TKIs | hypoxia | BMSC | leptin | Lung cancer | IGFBP2 | Index Medicus
Journal Article
Translational Lung Cancer Research, ISSN 2218-6751, 2012, Volume 1, Issue 4, pp. 283 - 286
Journal Article
International Journal of Cancer, ISSN 0020-7136, 08/2012, Volume 131, Issue 3, pp. E227 - E235
Journal Article
Chinese Journal of Lung Cancer, ISSN 1009-3419, 2018, Volume 21, Issue 3, pp. 241 - 250
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2019, Volume 145, Issue 5, pp. 1432 - 1444
Immune checkpoint inhibitors targeting the programmed cell death receptor/ligand 1 (PD‐1/PD‐L1) pathway have profoundly improved the clinical management of... 
lung cancer | EGFR‐TKIs | tumor microenvironment | ACTIVATION | IMMUNE CHECKPOINT INHIBITORS | ADENOCARCINOMA | EGFR-TKIs | CANCER | ONCOLOGY | CLASS-I | RESISTANCE | PD-L1 | SUPPRESSOR-CELLS | BLOCKADE | UP-REGULATION | Lung Neoplasms - drug therapy | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Molecular Targeted Therapy | Programmed Cell Death 1 Receptor - biosynthesis | Adenocarcinoma of Lung - drug therapy | Antineoplastic Agents - pharmacology | Adenocarcinoma of Lung - immunology | Acrylamides - pharmacology | Macrophages - immunology | Cytokines - blood | Cytokines - immunology | Disease Models, Animal | Tumor Microenvironment - drug effects | Gefitinib - pharmacology | Aniline Compounds - pharmacology | ErbB Receptors - antagonists & inhibitors | Lung Neoplasms - enzymology | Macrophages - pathology | Mice, Transgenic | Random Allocation | Adenocarcinoma of Lung - enzymology | Lung Neoplasms - immunology | Animals | B7-H1 Antigen - antagonists & inhibitors | Lymphocytes, Tumor-Infiltrating - pathology | B7-H1 Antigen - biosynthesis | ErbB Receptors - biosynthesis | Mice | Protein Kinase Inhibitors - pharmacology | Lymphocytes, Tumor-Infiltrating - immunology | Dendritic cells | T cells | Lung cancer, Non-small cell | Cell death | Analysis | Tumors | Medical research | Therapy | Epidermal growth factor receptors | CD8 antigen | Lung cancer | Clinical trials | Non-small cell lung carcinoma | Cytotoxicity | Lymphocytes T | Inflammation | Shrinkage | Macrophages | Suppressor cells | Inhibitors | Immune checkpoint | Lymphocytes | Foxp3 protein | Antitumor activity | Microenvironments | Apoptosis
Journal Article
Chinese Journal of New Drugs, ISSN 1003-3734, 01/2014, Volume 23, Issue 2, pp. 235 - 240
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.